There are pockets of excellence around the world. There are components of the process that work exceedingly well in some jurisdictions. If any jurisdiction had this mapped out perfectly, I think we would be one of the first organizations to try to copy that jurisdiction as much as we could. What's being proposed, in particular by the expensive drugs for rare diseases working group, is truly innovative. Based on consultation and further discussion with assistant deputy ministers and deputy ministers at the jurisdictional level, if some of these provisions move forward it will alter the way drugs for rare diseases—highly specialized and complex drugs—move through the system and how patients and clinicians get access.
On November 6th, 2018. See this statement in context.